| Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene: use as a selectable marker for stable … RGK Donald, D Carter, B Ullman, DS Roos Journal of Biological Chemistry 271 (24), 14010-14019, 1996 | 486 | 1996 |
| Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant RN Coler, S Bertholet, M Moutaftsi, JA Guderian, HP Windish, SL Baldwin, ... PloS one 6 (1), e16333, 2011 | 402 | 2011 |
| An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates JH Erasmus, AP Khandhar, MA O’Connor, AC Walls, EA Hemann, ... Science translational medicine 12 (555), eabc9396, 2020 | 208 | 2020 |
| Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation … RN Coler, YAW Skeiky, K Bernards, K Greeson, D Carter, CD Cornellison, ... Infection and immunity 70 (8), 4215-4225, 2002 | 181 | 2002 |
| ADRKNOCORTICAL FUNCTION AND CORTISOL METABOLISM IN OLD AGE CD West, H Brown, EL Simons, DB Carter, LF Kumagai, E Englert Jr The Journal of Clinical Endocrinology & Metabolism 21 (10), 1197-1207, 1961 | 158 | 1961 |
| Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer D Carter, JF Douglass, CD Cornellison, MW Retter, JC Johnson, ... Biochemistry 41 (21), 6714-6722, 2002 | 145 | 2002 |
| Mammaglobin: a candidate diagnostic marker for breast cancer BK Zehentner, D Carter Clinical biochemistry 37 (4), 249-257, 2004 | 142 | 2004 |
| Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis RC Hendrickson, JF Douglass, LD Reynolds, PD McNeill, D Carter, ... Journal of Clinical Microbiology 38 (6), 2354-2361, 2000 | 138 | 2000 |
| Optimized subunit vaccine protects against experimental leishmaniasis S Bertholet, Y Goto, L Carter, A Bhatia, RF Howard, D Carter, RN Coler, ... Vaccine 27 (50), 7036-7045, 2009 | 114 | 2009 |
| Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles D Carter, D Kalamasz US Patent App. 11/541,383, 2007 | 114 | 2007 |
| Compositions and methods for the therapy and diagnosis of prostate cancer J Xu, DC Dillon, JL Mitcham, SL Harlocker, Y Jiang, MD Kalos, GR Fanger, ... US Patent 6,800,746, 2004 | 114 | 2004 |
| Targeting TLRs expands the antibody repertoire in response to a malaria vaccine SR Wiley, VS Raman, A Desbien, HR Bailor, R Bhardwaj, AR Shakri, ... Science translational medicine 3 (93), 93ra69-93ra69, 2011 | 113 | 2011 |
| Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop MA Schumacher, D Carter, DS Roos, B Ullman, RG Brennan Nature structural biology 3 (10), 881-887, 1996 | 111 | 1996 |
| Glucopyranosyl lipid adjuvant (GLA), a synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140 MA Arias, GA Van Roey, JS Tregoning, M Moutaftsi, RN Coler, ... PloS one 7 (7), e41144, 2012 | 108 | 2012 |
| Vaccine composition containing synthetic adjuvant SG Reed, D Carter US Patent 8,273,361, 2012 | 93* | 2012 |
| A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7 CB Fox, SJ Sivananthan, MS Duthie, J Vergara, JA Guderian, E Moon, ... Journal of nanobiotechnology 12, 1-9, 2014 | 92 | 2014 |
| WT1-specific serum antibodies in patients with leukemia A Gaiger, L Carter, H Greinix, D Carter, PD McNeill, RL Houghton, ... Clinical cancer research 7 (3), 761s-765s, 2001 | 92 | 2001 |
| Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL‐18, and IFN‐γ AL Desbien, SJ Reed, HR Bailor, ND Cauwelaert, JD Laurance, MT Orr, ... European journal of immunology 45 (2), 407-417, 2015 | 88 | 2015 |
| The science of vaccine adjuvants: advances in TLR4 ligand adjuvants SG Reed, FC Hsu, D Carter, MT Orr Current opinion in immunology 41, 85-90, 2016 | 87 | 2016 |
| Hypoxanthine-guanine phosphoribosyltransferase as a therapeutic target in protozoal infections. B Ullman, D Carter Infectious agents and disease 4 (1), 29-40, 1995 | 86 | 1995 |
